The application of human embryonic stem cell technologies to drug discovery.
about
Induced pluripotent stem cells as a disease modeling and drug screening platformInduced Pluripotent Stem Cell Models to Enable In Vitro Models for Screening in the Central Nervous SystemNon-Invasive Acoustical sensing of Drug-Induced Effects on the Contractile Machinery of Human Cardiomyocyte Clusters.Isolation, differentiation and characterization of vascular cells derived from human embryonic stem cells.Stem Cell Therapy: A New Treatment for Burns?Characterisation of human embryonic stem cells conditioning media by 1H-nuclear magnetic resonance spectroscopy.Non-invasive imaging of human embryonic stem cells.Human-induced pluripotent stem cells: in quest of clinical applications.Determine the quality of human embryonic stem colonies with laser light scattering patterns.Stem cells and small molecule screening: haploid embryonic stem cells as a new tool.Chromosomal Modification in Human Embryonic Stem Cells Cultured in a Feeder-Free Condition after Single Cell Dissociation using Accutase.Proliferation and pluripotency of human embryonic stem cells maintained on type I collagen.Enhancement of Transgene Expression by HDAC Inhibitors in Mouse Embryonic Stem Cells.High-throughput cellular microarray platforms: applications in drug discovery, toxicology and stem cell researchCellular models for disease exploring and drug screeningIn vivo biodistribution of stem cells using molecular nuclear medicine imaging.Keeping the rhythm: hERG and beyond in cardiovascular safety pharmacology.Large-scale compatible methods for the preservation of human embryonic stem cells: current perspectives.Ion channel drug discovery: challenges and future directions.Improvement of cardiac efficacy and safety models in drug discovery by the use of stem cell-derived cardiomyocytes.The 3R principle: advancing clinical application of human pluripotent stem cells.Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype.Wnt inhibition correlates with human embryonic stem cell cardiomyogenesis: a structure-activity relationship study based on inhibitors for the Wnt responseHuman embryonic stem cell proliferation and differentiation as parameters to evaluate developmental toxicity.Generation of site-specific retargeting platform cell lines for drug discovery using phiC31 and R4 integrases.Expression of microRNAs and their target mRNAs in human stem cell-derived cardiomyocyte clusters and in heart tissue.Gene expression profiling of functional murine embryonic stem cell-derived cardiomyocytes and comparison with adult heart: profiling of murine ESC-derived cardiomyocytes.Spheroid culture for enhanced differentiation of human embryonic stem cells to hepatocyte-like cellsOverview of Electrophysiological Techniques.Gas/liquid sensing via chemotaxis of Euglena cells confined in an isolated micro-aquarium.Stemazole promotes survival and preserves stemness in human embryonic stem cells.Microfluidic-Nanofiber Hybrid Array for Screening of Cellular Microenvironments.Isolation of rat embryonic stem-like cells: a tool for stem cell research and drug discovery.
P2860
Q26865689-2FBE8361-591F-4E0E-B3D0-83373B7DDE82Q28082668-98ADC103-C142-4EAA-9781-5E803F1E9C48Q28547148-C0E984AC-2C87-4BB5-A556-DDED569FC9FAQ33760945-477773FD-7520-47FB-BBD6-89784DCEE579Q33765265-39E6CE36-CBF6-4AB7-BCA6-A0F52F1441B3Q33828823-4B793602-7C5A-4ED8-9B8B-B0236633BB6CQ34050057-06C76631-1741-4620-BB2E-726FDE33D46FQ34251675-4AF612C5-84FB-4647-9C94-DF4882E1EBCEQ34547305-EAA822A4-1210-43A3-9E3A-D1391A551792Q34706451-8C9F1633-4A4F-48CC-BC36-B770F97375DCQ34804422-195D2F75-D85C-47ED-AE09-34FA90EC2443Q35101952-6AFE323F-2AAE-41E5-9293-5D492A703FC3Q35246651-AD29FF72-E3B6-40DB-B99E-AE1FAF327D23Q37461728-04BF2801-0B31-4C56-8373-5E714CA9B2FCQ37825825-6D771B9B-CEB1-4914-9BB0-44BDD25B652FQ37853947-E1416CF8-BB44-44FF-8DA0-816A53F9AC54Q37960089-9F6B9BC6-496D-4F1D-869F-5B04B905C5FBQ37974907-3EEEB655-F252-4197-8C8F-A07606FDB4EBQ37998135-44685284-EBCE-43C9-8982-C74791876785Q38088809-BF16D4DB-FB0C-4CAB-AF67-583FC63A1CEBQ38091180-4E1475A6-DB1C-4C54-8FC1-56E7D92AC4CFQ39129176-4C9583F4-27A9-47C9-88BF-24B581B6C47FQ39423997-616C3591-9B3F-40D9-A76A-5AA11C17A729Q39644391-4B157BFF-BD45-4950-BD26-AFC027517D6CQ39788824-6D53B37E-AE0B-49B1-BF7D-36D89EB3C663Q39837840-39ED4929-CF8F-4719-9889-C4961B3A90B0Q39884759-FA374CA3-94C3-4FC1-B53C-FF32CC3397F0Q41863865-D1903F87-EAC9-451C-9F36-907229D9D27AQ43872489-C7706682-29BF-4958-BA3B-A3E17002BC51Q46972400-CA73AD02-8436-487C-8BC5-FCDF602C9D2BQ49985191-7FF2C689-7052-4BB7-B1F4-BD8A1AF9F439Q50970227-8A743D09-1557-415E-B6E3-9101774361B2Q51850250-E89FF8F1-A1D7-448C-A211-A1D2317FDF08
P2860
The application of human embryonic stem cell technologies to drug discovery.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The application of human embryonic stem cell technologies to drug discovery.
@en
type
label
The application of human embryonic stem cell technologies to drug discovery.
@en
prefLabel
The application of human embryonic stem cell technologies to drug discovery.
@en
P2093
P1433
P1476
The application of human embryonic stem cell technologies to drug discovery.
@en
P2093
Johan Hyllner
Peter Sartipy
Petter Björquist
Raimund Strehl
P304
P356
10.1016/J.DRUDIS.2007.07.005
P577
2007-08-30T00:00:00Z